1. Understanding Renal Cell CarcinomaRonald M. Bukowski, MD Emeritus Staff, Consultant Cleveland Clinic Taussig Cancer Center Cleveland, Ohio 2. Overview 3. RCC Statistics…

1. CÁNCER DE MAMA TERÁPIAS ÓSEAS 2. CA DE MAMA TEMPRANO: PREVENCIÓN DE FX AUMENTO DE LA SLE CON TERAPIAS ADYUVANTES ÓSEAS ENFERMEDAD METASTASICA 3. Predictors of Fracture…

Non-Hodgkin’s Lymphoma Epidemiology, Disease and Staging Haematopoietic Malignancies Myeloproliferative diseases chronic myeloid leukaemia (CML) Polycythemia vera (PV)…

1. IASO Quiz 2013 Instituted by Dr Panda and Dr K Gopinath 2. Identify this cancer survivor 3. Identify this cancer survivorLance Armstrong 4. Following the 2012 USPSTF recommendation…

1. JOURNAL CLUB 13/09/2012 DR. R. RAJKUMAR III YR POST GRADUATEDEPARTMENT OF MEDICAL ONCOLOGY 2. Question 1• Important prognostic factors in breastcancer include:– A.…

1. Regulatory Analysis &Approval of BiosimilarsPlenary Lecture at Ganpat UniversityMehsana, Gujarat, July 20, 2012Dr. Bhaswat S. Chakraborty20.07.2012 2. Contents…

1. Care of the Cancer SurvivorEva Grunfeld, MD, DPhil, FCFPOntario Institute for Cancer Research, andDept of Family and Community Medicine,University of Toronto 2. No conflicts…

Slide 1Il tumore mammario nelle giovani donne Lucia Del Mastro SS Sviluppo Terapie Innovative 12 maggio 2012 IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto…

Slide 1Education of patients taking capecitabine EORTC 10041 BIG 3-04 Intergroup Study MINDACT (Microarray In Node-negative Disease may Avoid ChemoTherapy): A prospective,…

Slide 1Pre-operative Imatinib for metastatic, recurrent and locally advanced GISTs E. Efthimiou, S Mudan E. Efthimiou, S Mudan On behalf of the Sarcoma Group The Royal Marsden…